Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
British Journal of Haematology (2013)
  • Lihua E. Budde, Fred Hutchinson Cancer Research Center
  • Michelle M. Zhang, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • George R. Oliveira, Harvard University
  • Tara L. Chen, University of Washington
  • Nancy L. Knudsen, Fred Hutchinson Cancer Research Center
  • Jennifer E. Roden, University of Washington
  • Britt E. Kammerer, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Thomas A. Warr
  • Thomas E. Boyd, Memorial Hospital of South Bend
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 4, 2013
DOI
10.1111/bjh.12230
Citation Information
Lihua E. Budde, Michelle M. Zhang, Andrei R. Shustov, John M. Pagel, et al.. "A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma." British Journal of Haematology Vol. 161 Iss. 2 (2013) p. 183 - 191
Available at: http://works.bepress.com/john-pagel/137/